国际推荐:影像学在风湿性多肌痛诊断与评估中的应用
该国际推荐由12国30名专家组成的多学科工作组制定,基于系统文献综述和专家意见,针对超声、MRI和FDG-PET在风湿性多肌痛诊断、监测及预后预测中的作用提出3项总体原则和7条推荐。核心结论为风湿性多肌痛仍主要依靠临床诊断,影像学最适用于中等验前概率(不典型表现或怀疑重叠疾病)的患者,不推荐用于疾病监测或预后预测。
要点
- 高临床概率患者无需影像确认风湿性多肌痛,低概率患者也无需影像排除。
- 影像学最有价值的情景是中等验前概率,即不典型表现或怀疑其他/重叠疾病。
- 无单一影像 modality 可作为一线检查,应根据临床表现、鉴别诊断、可及性和本地专长个体化选择。
核心结论
- 风湿性多肌痛仍主要是临床诊断,影像学是情境驱动的辅助手段而非确诊工具。
- 影像学最适用于中等验前概率(不典型表现或怀疑其他/重叠疾病)的患者。
- 不推荐常规使用影像学进行疾病监测或预后预测。
研究设计与样本
- 国际多学科工作组制定推荐,共30名成员来自12个国家。
- 遵循欧洲抗风湿病联盟标准操作流程,基于6个临床关键问题的系统文献综述。
- 推荐基于证据和专家意见形成,经迭代优化至达成共识,并通过投票评估同意程度。
诊断标准与关键数值
- 提出3项总体原则和7条推荐。
- 无单一影像 modality(超声、MRI、FDG-PET)显示足够准确性被推荐为一线检查。
- 怀疑重叠巨细胞动脉炎时应进行血管影像学检查;不推荐系统筛查亚临床血管炎。
临床应用与阅片要点
- 高临床概率患者无需影像确认风湿性多肌痛,低概率患者也无需影像排除。
- 中等验前概率(不典型表现或怀疑其他/重叠疾病)时影像学最有帮助。
- 根据临床表现、鉴别诊断、影像可及性和本地专长个体化选择影像 modality。
- 怀疑重叠巨细胞动脉炎时行血管影像学检查,但不建议系统筛查亚临床血管炎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The study aims to develop international recommendations for the use of imaging in the diagnosis and assessment of polymyalgia rheumatica (PMR).
METHODS: An international, multidisciplinary task force of 30 members from 12 countries was convened; the European Alliance of Associations for Rheumatology standard operating procedures were followed. Six clinical key questions addressing the role of imaging (ultrasound, magnetic resonance imaging, and 18F-fluorodeoxyglucose positron emission tomography) in diagnosis, monitoring, outcome prediction, and technical aspects in PMR were the basis for a systematic literature review. Recommendations were formulated based on evidence and expert opinion and refined iteratively until consensus was achieved. The level of agreement was assessed by voting.
RESULTS: Three overarching principles and 7 recommendations were developed. PMR remains primarily a clinical diagnosis. Imaging is neither required to confirm PMR in patients with a high clinical probability of the disease nor to exclude PMR in case of low clinical probability. Imaging is most useful in patients with intermediate pretest probability (ie, atypical presentations or suspected alternative/overlapping conditions). No single imaging modality demonstrated sufficient accuracy to be recommended as a first-line test; therefore, imaging should be individualised according to clinical presentation, differential diagnoses, access, and local expertise. Vascular imaging should be performed when overlap with giant cell arteritis is suspected, whereas systematic screening for subclinical vasculitis is not supported by current evidence. Utilising imaging for disease monitoring or outcome prediction is currently not recommended.
CONCLUSIONS: These recommendations provide the first evidence-based guidance for the use of imaging in PMR, reinforcing clinical assessment as the cornerstone of diagnosis and positioning imaging as a context-driven adjunct.
引用
- Bond M, Hysa E, Konzett V, et al. International recommendations for the use of imaging in the diagnosis and assessment of polymyalgia rheumatica. Ann Rheum Dis. 2026. PMID: 42946585. doi:10.1016/j.ard.2026.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。